1
Clinical Trials associated with Pneumococcal polysaccharide vaccine 23-valent(Beijing Hua'an Innovation Biotechnology)评价23价肺炎球菌多糖疫苗在2岁及以上健康人群中接种后的安全性和初步探索免疫原性的随机、盲法、平行对照Ⅰ期临床试验
[Translation] A randomized, blinded, parallel controlled phase I clinical trial to evaluate the safety of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and above and to preliminarily explore the immunogenicity
通过对不同年龄人群接种23价肺炎球菌多糖疫苗后的观察,评价23价肺炎球菌多糖疫苗在相应年龄健康人群中的安全性和初步免疫原性。
[Translation] By observing people of different ages after vaccination with 23-valent pneumococcal polysaccharide vaccine, the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people of corresponding ages were evaluated.
100 Clinical Results associated with Pneumococcal polysaccharide vaccine 23-valent(Beijing Hua'an Innovation Biotechnology)
100 Translational Medicine associated with Pneumococcal polysaccharide vaccine 23-valent(Beijing Hua'an Innovation Biotechnology)
100 Patents (Medical) associated with Pneumococcal polysaccharide vaccine 23-valent(Beijing Hua'an Innovation Biotechnology)
100 Deals associated with Pneumococcal polysaccharide vaccine 23-valent(Beijing Hua'an Innovation Biotechnology)